Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
Monday, November 04, 2013
Cambridge Major Laboratories, Inc. (“CML”), a global leader in pharmaceutical API development and manufacturing, and AAIPharma Services, Corp. (“AAIPharma”), a leading global provider of pharmaceutical analytical testing, product development and ...
read more
Monday, November 04, 2013
The CPhI Pharma Awards 2013 winners were announced live at the awards ceremony- day one at CPhI Worldwide. Honouring outstanding developments from some key industry players, the awards highlighted ever-advancing market innovations, fundamental to ...
read more
Monday, November 04, 2013
Almac’s Clinical Services Business Unit is delighted to announce that Richard Segiel, Jr. has joined the company as Vice President of Business Development for the United States. He brings with him 23 successful years of experience in the contract ...
read more
Thursday, October 31, 2013
Quality by Design (QbD) and its systematic approach to development begins with a predefined objective and emphasizes sound science and quality risk principles as an integral part of product development and process control implementation, and can help...
read more
Thursday, October 31, 2013
Royal DSM, the global Life Sciences and Materials Sciences company, today announced it has signed an agreement with the Sanquin Blood Supply Foundation (Sanquin) for the commercial manufacture of a monoclonal antibody used for the recovery and ...
read more
Thursday, October 31, 2013
The U.S. regulatory landscape changed dramatically 10 years ago. In 2003, legal roadblocks to the 505(b)(2) approval pathway were resolved, making it a practical alternative route for drug development. That same year, Ken Phelps and Ruth Stevens ...
read more
Thursday, October 31, 2013
Argenta, a Galapagos NV (Euronext: GLPG) company that provides drug discovery services from target validation to proof of concept, today announces a three-year extension of its integrated contract drug discovery agreement with Genentech, a member of ...
read more
Thursday, October 31, 2013
“The launch of the new brand logo is an outward sign of an important transformation that’s been ongoing for the past couple of years,” said John D. Bucksath, President and CEO. “The entire organization has worked very hard to get where we are today. ...
read more
Thursday, October 24, 2013
With the opening of a new commercial packaging facility in the US and enhanced processing capabilities at the company’s Headquarters in Craigavon, UK, investments in the past year has substantially transformed the commercial business unit of Almac.
read more
Thursday, October 24, 2013
Norwich Pharmaceuticals, a provider of full-service contract development and manufacturing services for the pharmaceutical and biotech industry, today announced that it has changed its name to Norwich Pharma Services. The new name and brand identity ...
read more
Thursday, October 24, 2013
The loss of drug product during the filtration and fill process presents a major challenge to pharmaceutical and biologics manufacturers worldwide. For Cobra Biologics, a leading CMO providing aseptic manufacture for clinical and commercial supply, ...
read more
Tuesday, October 22, 2013
The Aenova Group, one of the leading companies in the pharmaceutical and healthcare industry, is continuing its successful period of growth. As Aenova has already announced, it has found in Haupt Pharma, a company specializing in contract development...
read more
Tuesday, October 22, 2013
Global pharmaceutical chemistry leader Cambridge Major Laboratories Europe, B.V. (CML-Europe) is pleased to announce the successful completion of its first Food and Drug Administration inspection. The inspection included a pre-approval inspection and...
read more
Thursday, October 17, 2013
Pharmaceutical contract development and manufacturing organizations (CDMOs) DPT Laboratories, based in San Antonio, Texas, and Confab, based in Saint-Hubert, Quebec, today announced the integration of the organizations under the leadership of Paul ...
read more
Thursday, October 17, 2013
Ben Venue Laboratories, Inc. (Ben Venue) of Bedford, Ohio, has decided to cease production by the end of 2013. Despite the ongoing support of the U.S. Food and Drug Administration (FDA), the tremendous dedication of employees, and significant ...
read more